title: Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.
authors.forename: A
authors.initials: A
authors.lastname: Dupuis
authors.forename: M P
authors.initials: MP
authors.lastname: Gaub
authors.forename: M
authors.initials: M
authors.lastname: Legrain
authors.forename: B
authors.initials: B
authors.lastname: Drenou
authors.forename: L
authors.initials: L
authors.lastname: Mauvieux
authors.forename: P
authors.initials: P
authors.lastname: Lutz
authors.forename: R
authors.initials: R
authors.lastname: Herbrecht
authors.forename: S
authors.initials: S
authors.lastname: Chan
authors.forename: P
authors.initials: P
authors.lastname: Kastner
mesh_terms: D000328:Adult; D002648:Child; D057895:Haploinsufficiency / Q000235:genetics*; D006801:Humans; D051740:Ikaros Transcription Factor / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*; D011379:Prognosis
chemical_list: C497239:IKZF1 protein, human; D051740:Ikaros Transcription Factor